Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Iranian Researchers' Method to Produce Nickel Oxide Nanopowders Receives US Patent

Abstract:
The United States Patent and Trademark Office (USPTO) recently issued a patent (US 8,110,173) disclosing a new and simple method for fabrication of nickel oxide nanopowders invented by a group of Iranian researchers.

Iranian Researchers' Method to Produce Nickel Oxide Nanopowders Receives US Patent

Tehran, Iran | Posted on August 16th, 2012

"So far, I have patented two inventions concerning the production of nickel oxide nanopowders both in Iran and the US in joint collaborations with my colleagues. The first one involves the utilization of aqueous phases while the other one is based on organic phases," Dr. Seyed Khatibol Eslam Sadrnejad, one of the inventors who is an MIT PhD graduate in Materials Science and Engineering (class of 1978), explained to the News Service of Iran Nanotechnology Initiative Council (INIC).

"In the current research, we were mainly after a novel, simple and inexpensive alternative method of synthesis of such metal oxide nanopowders," he added.

"Being based on the known solvothermal technique, our invented production process is straightforward and conveniently handled. In a simplified form, the employed synthesis procedure can be described as follows: A specific salt of nickel is first dissolved in an appropriately selected alcohol and then gradually heated and continually stirred in order to make a precipitation reaction occur. After a sufficient period of time, the yielded participate undergoes filtration, drying and calcinations steps, orderly. The ultimate product is chip-like particles having nanometric dimensions and thanks to their very high specific surface areas, they hold promise for applications in energy storage, electronics, optics, process control and particularly catalysis technology. A distinct advantage of our proposed scheme over the previous methods is in not having to use any surfactants (surface active agents) which are relatively costly compounds."

Summarizing his views regarding the commercialization of the invention, Dr. Sadrnejad said, "Implementation of our proposed NiO nanoparticles fabrication method on large scales seems to be economic for our country and we welcome any offers from investors on the topic."

This research project has been funded by Iran National Science Foundation (INSF) together with the INIC. In addition, the patent registration costs were covered in part by the INIC.

####

For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Making sense of metallic glass February 9th, 2016

Electron's 1-D metallic surface state observed: A step for the prediction of electronic properties of extremely-fine metal nanowires in next-generation semiconductors February 9th, 2016

Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Announcements

Making sense of metallic glass February 9th, 2016

Electron's 1-D metallic surface state observed: A step for the prediction of electronic properties of extremely-fine metal nanowires in next-generation semiconductors February 9th, 2016

Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Patents/IP/Tech Transfer/Licensing

Joint Efforts by Iranian, Malaysian Scientists Produce Antibacterial Coatings for Isolated Areas February 4th, 2016

Silicon-based metamaterials could bring photonic circuits February 1st, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016

Light-activated nanoparticles prove effective against antibiotic-resistant 'superbugs' January 19th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic